Vetter goes green and supplies German sites with neutral energy

By Maggie Lynch

- Last updated on GMT

(Image: Getty/macky_ch)
(Image: Getty/macky_ch)
Vetter’s German sites will be supplied with only CO2 neutral energy from renewable energy sources as the company continues to work towards greater sustainability.

The contract and development manufacturing organization (CDMO) announced its sustainability milestone prior to its attendance at BIO International, which takes place next week in Philadelphia, PA.

Thomas Otto, managing director of Vetter, explained that supplying its German sites with green electricity is a part of its company-wide program for environmental protection, energy management, and occupational health and safety.

A spokesperson for the company told us, “It is imperative that we produce high-quality products, because as a biopharmaceutical and pharmaceutical service provider, ultimately, these products enter the human body. We look beyond the products and services we offer and recognize the impact our company can have on others.”

Vetter stated that within the next ten years it plans to use CO2 neutral energy company-wide and offset any unavoidable CO2 emissions with investments in climate protection projects.

“For us this means an alliance of economy, ecology, and social responsibility. This is not just a company philosophy but integrated in our daily work, in our departments and processes,”​ the spokesperson added.

Serving members of both the pharmaceutical and biotechnology industry, the Germany-based company has received certification that it has met the standards for environmental protection, energy management, and occupational health and safety.

Additionally, the CDMO recently established its center for visual inspection and logistics​, which in 2018 received the international industry prize, Facility of the Year Award. The site uses block heating and geothermal energy among systems to make the site as energy-efficient as possible.

Related news

Show more

Related products

show more

Ultra Low Temperature Packaging solutions

Ultra Low Temperature Packaging solutions

Content provided by Almac Group | 12-Feb-2024 | Case Study

Advanced Therapy Medicinal Products (ATMPs) offer ground-breaking opportunities for treating injuries and disease, in particular for cases of severe, untreatable...

Pulmonary Delivery of Orally Inhaled Therapeutics

Pulmonary Delivery of Orally Inhaled Therapeutics

Content provided by Catalent Pharma Solutions | 19-Oct-2023 | Product Brochure

New classes and indications of orally inhaled therapeutics are rapidly expanding, with the development pipeline increasingly featuring both large and small...

Addressing Challenges with Clinical In-Use Testing

Addressing Challenges with Clinical In-Use Testing

Content provided by Lonza | 12-Oct-2023 | White Paper

Lonza Drug Product expert Léa Sorret PhD explores Clinical In-Use Testing of Biotherapeutics in this white paper. Léa shares her expertise and describes...

Related suppliers

Follow us

Products

View more

Webinars